Arie Belldegrun
Director · UroGen Pharma Ltd.
Individual
- 2025
- Jun 24, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Arie Belldegrun files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Schoenberg - $4.48M in URGN purchases and sales in the last 12 months
- David D. Chang - $289K in ALLO purchases and sales in the last 12 months
- Jason Drew Smith - $212K in URGN purchases and sales in the last 12 months
- Zachary Roberts - $104K in ALLO purchases and sales in the last 12 months
- Earl Martin Douglas - $103K in ALLO purchases and sales in the last 12 months
- Geoffrey M. Parker - $88K in ALLO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arie Belldegrun?
Arie Belldegrun is a corporate insider, tracked as Director of UroGen Pharma Ltd. (URGN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Arie Belldegrun last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 4 filings going back to 2025.
